Dose Reduction in Thoracic CT: A Comparison of on Line Automatic Dose Reduction and a 50% Reduction in Dose
16 Years
N/A
Both
Lymphoma
Trial Information
Dose Reduction in Thoracic CT: A Comparison of on Line Automatic Dose Reduction and a 50% Reduction in Dose
Patients with Lymphoma are recruited and have a follow up CT performed at 50% of the
standard exposure parameters. The studies are compared for image quality with a recent (<3
months) thoracic CT performed at standard exposure parameters.
Inclusion Criteria:
- Patients with Lymphoma
Exclusion Criteria:
- No recent (<3 months) thoracic CT
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Evaluating the diagnostic quality of thoracic CT exams performed at 50% of standard dose parameters
Principal Investigator
Narinder Paul, FRCP C
Investigator Role:
Principal Investigator
Investigator Affiliation:
University Health Network, Toronto
Authority:
Canada: Health Canada
Study ID:
03-0875
NCT ID:
NCT00188461
Start Date:
January 2004
Completion Date:
August 2005
Related Keywords:
- Lymphoma
- Lymphoma
Name | Location |
|---|
